PMDA drug package insert
ビザミル静注
PMDA Prescription drug · 日本メジフィジックス株式会社 · package insert Nov 20, 2024
Key facts
| Brand names | ビザミル静注 |
|---|---|
| Nonproprietary names | フルテメタモル（１８Ｆ） |
| Companies | 製造販売元／日本メジフィジックス株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 放射性医薬品 |
| Therapeutic category codes | 874300 |
| YJ codes | 4300454A1022 |
| Approval numbers | 22900AMX00957000 |
| Package insert edition | 第5版 |
| Package insert date | Nov 20, 2024 |
| PMDA document key | 530359_4300454A1022_1 |
| PMDA company code | 530359 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: